We’ve long known rosemary as the fragrant, piney herb that jazzes up roasted potatoes or brings depth to chicken stew. But while it’s been a culinary favorite and even a symbolic herb in folklore and ceremonies (“rosemary for remembrance,” as Shakespeare wrote), science is now giving it a new reputation—one that could change the way we understand and treat neurodegenerative diseases like Alzheimer’s.
Recent findings suggest that rosemary may be more than just an aromatic garnish—it might hold chemical keys to protecting the brain, preserving memory, and even reversing the biological processes that cause cognitive decline.
A Promising Compound Hidden in Rosemary and Sage
At the heart of this breakthrough is a molecule called carnosic acid, a naturally occurring antioxidant found in rosemary and its cousin sage. Antioxidants are the body’s frontline defenders against free radicals—those unstable molecules that build up due to stress, pollution, aging, and inflammation. Free radicals can damage cells, including brain cells, over time. In diseases like Alzheimer’s, oxidative stress and inflammation are two of the most destructive forces behind the scenes.
Carnosic acid has already been known in the scientific world for its powerful anti-inflammatory and neuroprotective effects. However, until recently, its medicinal value remained largely untapped. That’s because the molecule, in its raw herbal form, is too unstable to use effectively in medication—it degrades quickly and doesn’t survive the journey through the digestive tract or bloodstream.
That’s where innovation came in.
From Herb to High-Tech: The Birth of diAcCA
Researchers at The Scripps Research Institute didn’t just admire carnosic acid for its potential—they reengineered it. They developed a more stable version called diAcCA (short for di-acetylated carnosic acid), a synthetic compound that holds up well during digestion and is then transformed back into its active form once inside the body.
Think of it like a special capsule for carnosic acid. Once ingested, diAcCA makes its way to the gut, where it’s converted into its active form and then absorbed into the bloodstream. From there, it travels to the brain, where it gets to work.
And the results in lab tests have been nothing short of intriguing.
Read more: Chewing Gum Sets Off Microplastic Bombs In Your Mouth, Study Reveals
What Happens When Mice with Alzheimer’s Are Treated With diAcCA?
The scientists tested the compound in mice that were genetically modified to exhibit symptoms of Alzheimer’s disease. These mice, much like human patients, showed memory deficits, brain inflammation, and accumulation of problematic proteins like amyloid-beta and phosphorylated tau. These sticky proteins clump together, forming plaques and tangles that choke off neuron communication—hallmarks of Alzheimer’s pathology.
But after receiving diAcCA treatment, something remarkable happened.
✔ Improved Memory and Learning
Cognitive testing showed that the mice began performing better in memory tasks. They navigated mazes more efficiently and remembered familiar objects more accurately. According to Dr. Stuart Lipton, senior author of the study, these improvements weren’t just minor—they were substantial enough to suggest a reversal of symptoms.
“We didn’t just slow the decline—we restored memory back to near-normal levels,” Dr. Lipton said.
✔ A Rewiring of the Brain?
Microscopic analysis revealed that the treated mice had increased synaptic density. In simpler terms, their brain cells were forming more connections. Since synapses are where neurons talk to each other, more synapses generally means better communication between brain cells, which translates to sharper thinking and better memory.
✔ A Blow to Inflammation and Misfolded Proteins
Perhaps even more importantly, the compound reduced inflammation in the brain—a key factor in the progression of Alzheimer’s. Chronic inflammation is like a wildfire in the brain, damaging neurons and accelerating cognitive decline.
diAcCA didn’t stop there. It also reduced the levels of amyloid-beta and tau proteins. These toxic clumps are believed to disrupt cell function and kill neurons, so reducing them could directly slow or even halt the disease’s progression.
Read more: The Kinds Of Proteins You Should Eat Every Week, According to a Dietitian
A Precision Medicine Breakthrough: Activated Only Where Needed
One of the biggest concerns with brain drugs is that they can affect healthy tissue and cause unwanted side effects. That’s not the case with diAcCA. This compound is “selectively activated”—meaning it only switches on in areas of the brain experiencing inflammation. It’s like a firefighter who only shows up where there’s smoke, rather than spraying the whole forest.
This selective targeting could make diAcCA significantly safer than existing medications that flood the brain with chemicals regardless of need.
What Makes diAcCA So Exciting for Human Trials?
Here’s a twist that might fast-track this compound into human clinical trials: carnosic acid is already recognized as safe by the U.S. Food and Drug Administration (FDA). It’s on the GRAS (Generally Recognized As Safe) list, which means it has a long history of safe consumption in food.
This doesn’t mean diAcCA is already approved—it’s still a new, altered version of the original compound. But starting with a GRAS-listed base ingredient can make the regulatory process smoother. It removes one of the biggest hurdles in drug development: proving a compound isn’t toxic.
The team at Scripps hopes to take advantage of this momentum to start trials in humans, where they can test the drug’s efficacy and safety on people already experiencing Alzheimer’s symptoms.
Why Rosemary and Alzheimer’s? A Natural Fit
It might seem strange that something as simple as rosemary could be connected to one of the most complex diseases known to science. But it’s not the only time plants have surprised researchers.
Nature has long been a source of powerful medicines—from aspirin (originally derived from willow bark) to chemotherapy agents based on periwinkle. The idea of mining plants for therapeutic compounds isn’t new, but what makes rosemary particularly intriguing is how it seems to protect brain cells directly.
Ancient cultures used rosemary not just for flavor but as a symbol of remembrance, burning it in funerals or planting it near graves. While they didn’t know the biochemistry, they might have sensed something meaningful about the herb’s connection to memory and cognition.
What’s Next? Potential Uses Beyond Alzheimer’s
Dr. Lipton and his colleagues aren’t stopping at Alzheimer’s. They’re also eyeing other conditions driven by inflammation and oxidative stress—two biological troublemakers that show up in a wide range of chronic illnesses.
Among the targets on their list:
- Parkinson’s disease – another neurodegenerative condition marked by abnormal protein clumping and dopamine loss.
- Type 2 diabetes – which has been increasingly linked to cognitive issues and inflammation.
- Heart disease – another condition where inflammation plays a key role in damage to blood vessels.
If diAcCA proves effective in these conditions, it could become part of a new class of drugs that don’t just treat symptoms but actually correct some of the cellular dysfunctions at the root of many modern diseases.
Should You Start Eating More Rosemary?
Tempting as it is to sprinkle rosemary on everything and call it a cure, the truth is a bit more nuanced. While rosemary in its natural form is safe and healthy—rich in antioxidants, anti-inflammatory compounds, and even mood-boosting properties—it doesn’t deliver the concentrated, targeted effects of diAcCA.
Still, enjoying rosemary regularly as part of a balanced diet is certainly not a bad idea. Herbs like rosemary and sage have long been staples in brain-friendly diets like the Mediterranean diet, which is associated with reduced risks of cognitive decline.
Read more: The Largest Single Organism On Earth Is Slowly Being Eaten
The Bigger Picture: A Future Without Cognitive Decline?
Alzheimer’s currently affects over 55 million people worldwide, and the numbers are expected to rise dramatically as the global population ages. It’s a disease with no known cure and only a handful of treatments that can slow symptoms temporarily. That’s why any new therapy offering even a glimmer of real reversal or prevention is greeted with cautious excitement.
What makes diAcCA so appealing is that it takes a multi-pronged approach: reducing inflammation, cleaning up toxic proteins, and restoring neuronal communication—all while being derived from something as commonplace and familiar as a kitchen herb.
Whether it turns out to be the game-changer scientists hope remains to be seen. But for now, rosemary has earned more than just a place in your spice rack—it may also belong in the growing toolbox of future neuroscience.
